Klingel medical metal group (“Klingel”), owned by the IK VIII Fund, announce that it has completed the acquisitions of Bächler Feintech AG (“Bächler”) and Gehring Cut AG (“Gehring”). Both companies are leading manufacturers of high-precision surgical instruments for the global MedTech market.
Bächler was founded in 1964 and employs 140 people at the production site in Hölstein, Switzerland, where state-of-the-art machinery and industry-leading quality management are established.
Gehring was founded in 1948 and employs 75 people at the production site in Matzingen, Switzerland, where similar to Bächler, a state-of-the-art machine park and industry-leading quality management are established.
Through these acquisitions, Klingel strengthens its position as the leading pan-European MedTech CMO for complex components and instruments. The extended platform enables the combined group to provide its broad global customer base with a more flexible service to meet their customers’ high quality requirements and to serve their ever-increasing demands.
“With Bächler and Gehring we have found the perfect complements to our MedTech platform. Through the acquisitions, we are gaining additional blue-chip customers, manufacturing capabilities and valuable expertise for our group, enabling us to create real value-add for our customers. In addition, we have found strong partners in the management teams of Bächler and Gehring and look forward to our next phase of growth as a larger pan-European group”, said Ralf Petrawitz, CEO of Klingel.
For further questions, please contact:
KLINGEL medical metal
Ralf Petrawitz, CEO
Phone: +49 7231 6519 0
IK Investment Partners
Anders Petersson, Partner
Phone: +49 40 369 8850
Mikaela Murekian, Director Communications & ESG
Phone: +44 77 87 573 566
mikaela.murekian@ikinvest.com
About KLINGEL medical metal
For more than 30 years, KLINGEL medical metal GmbH has been one of the leading European precision technology companies with a strategic focus on medical technology industries. Employing over 300 people, KLINGEL medical metal GmbH specialises in the precision processing of materials with low machinability, such as titanium and high-grade stainless steel. KLINGEL offers unrivalled technical quality and aesthetic perfection. For more information, visit www.klingel-med.de
About IK Investment Partners
IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK has raised more than €10 billion of capital and invested in over 125 European companies. IK funds support companies with strong underlying potential, partnering with management teams and investors to create robust, well-positioned businesses with excellent long-term prospects. For more information, visit www.ikinvest.com
